Mark Stevenson

Mark Stevenson focuses primarily on board service and selective advisory and investment activities across the life sciences industry.He serves as a Board Director of Ingersoll Rand, on the Supervisory Board of QIAGEN N.V., and on the Boards of Directors of Ultima Genomics and Harbinger Health, where he brings strategic and operational perspective drawn from decades of global scale-up and commercialization experience. He also serves as Senior Advisor at General Atlantic, supporting the firm's investment teams and portfolio companies in the life sciences sector, and as Operating Partner at Fivespan Partners, a value-oriented investment firm.Mark serves as Chairman of Camillus Capital, which invests across life sciences and healthcare and technology. This work builds on more than 30 years of operational leadership in the industry, including as Executive Vice President and Chief Operating Officer at Thermo Fisher Scientific, President/COO of Life Technologies, and Senior Partner at Flagship Pioneering.